ILUVATAR COREX's stock soared 6.78% during intraday trading on Monday, reflecting significant investor interest in the company.
The price surge was driven by a dual positive catalyst. Firstly, Huatai Securities initiated coverage on the company with a Buy rating and set a target price of HK$600.19. The brokerage highlighted ILUVATAR COREX as the first domestic manufacturer to achieve mass production of general-purpose GPU chips for both training and inference, with strong commercialization across finance, healthcare, and industrial applications.
Secondly, the company received a boost from Tencent's official release and open-sourcing of the Hunyuan Hy3 preview large model. ILUVATAR COREX provided critical support for the model's efficient inference and large-scale deployment through its fully self-developed computing infrastructure and deep optimization capabilities. Analysts remain optimistic about the company's prospects amid surging AI chip demand driven by large model development.
Comments